Reassessing My Strategy: Trading in a Shifting Market

This past week has been a time of reflection and action for my portfolio. With a lot of market uncertainty, I've been reassessing my approach to investing and making some changes. The backdrop, of course, is the ongoing discussion around the Federal Reserve's Jackson Hole meeting and the President's latest tariff movements. These are two major factors influencing market sentiment and a trader's decisions, and they've definitely been on my mind.

For my ETF strategy, I've started to shift away from some of the higher-risk investments I was holding. I've begun to focus more on funds that I believe will provide a more stable foundation, specifically preferred stock and Treasury-focused funds. This is a deliberate move to increase my exposure to income-generating assets and potentially reduce volatility in my overall holdings.

On the individual stock front, my trading has been quite active, with a focus on "swing trading" or capturing smaller, short-term price movements. My most active trading, this week, has been in the following stocks:

  • Pfizer Inc (PFE): I've been in and out of this stock a few times this week, making both purchases and sales.

  • The Campbell's Company (CPB): Similar to Pfizer, I've been actively trading in Campbell's, executing multiple buy and sell orders.

  • Conagra Brands Inc (CAG): This has been another frequent name in my recent trading activity, with a mix of purchases and sales.

  • Broadcom Inc (AVGO): I've been actively trading this tech company, with a net increase in my overall position.

My belief is that the future of the market lies in technology. While I am still trading in more traditional sectors, I am focusing on a select group of tech stocks that I believe have a transformative future. My goal is to use small, tactical movements to take advantage of short-term price swings and build larger positions in companies that I believe will define the next generation of innovation. I increased holdings on some Tech Companies, after a Market Manager shared a view, these companies are overpriced (I disagree):

  • Microsoft Corporation (MSFT): I bought the sharp price decline on 8/19.

  • Palantir (PLTR): I bought shares on 8/19 and 8/20, taking advantage of large declines from the recent peak.

  • Broadcom (AVGO): Also bought on the Tech Declines, 8/19 and 8/20, with one sale or a swing-trade.
This week, the CBOE Volatility Index (VIX) has shown a modest upward trend, reflecting a slight increase in market caution. After a calm period, the "fear index" saw a notable move higher from a low of around 14.99 on Monday to a close of 15.69 on Wednesday, suggesting a subtle shift in investor sentiment. While the VIX remains at a relatively low level compared to historical spikes, this move is significant as it breaks above a recent comfort zone and indicates a heightened awareness of potential market risks. The renewed focus on the Federal Reserve's stance and other macroeconomic factors, such as the President's tariff movements, is likely contributing to this uptick in expected volatility. This movement highlights the market's sensitivity to upcoming economic signals, even as the S&P 500 has been setting records.

It's an interesting time to be an investor, with so many macroeconomic factors at play. It requires constant attention and a willingness to adapt. This week, I've done just that, and I'm looking forward to seeing how these new strategies unfold.